Concepedia

Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons

Lisa A. Jackson, W. H. Chen, Jack T. Stapleton, C. L. Dekker, Anna Wald, Rebecca C. Brady, Srilatha Edupuganti, Patricia Winokur, Mark J. Mulligan, Harry Keyserling,

The Journal of Infectious Diseases · 2012 · 44 citations · 31 references

DOIFull text

Open access

Abstract

AS03 adjuvant system improves the immune response to inactivated 2009 H1N1 influenza vaccine in both younger and older adults and is generally well tolerated. ClinicalTrials.gov NCT00963157.

References

31

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial

Isabel Leroux‐Roels, Astrid Borkowski, Thomas Vanwolleghem et al. · The Lancet · 2007 · 500 citations

, , +9

Response to a Monovalent 2009 Influenza A (H1N1) Vaccine

Michael E. Greenberg, Michael H. Lai, Günter Härtel et al. · New England Journal of Medicine · 2009 · 492 citations · Full text

A Novel Influenza A (H1N1) Vaccine in Various Age Groups

Fengcai Zhu, Hua Wang, Han-hua Fang et al. · New England Journal of Medicine · 2009 · 341 citations · Full text

Half- vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005)

Renata J.M. Engler · Archives of Internal Medicine · 2008 · 319 citations

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial

Xiaofeng Liang, Huaqing Wang, Junzhi Wang et al. · The Lancet · 2009 · 254 citations

, , +10